Acadia Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€27.40
Target price
19.12.24
€36.48
Performance (%)
-41.15%
End price
20.12.24
€16.13
Summary
This prediction ended on 20.12.24 with a price of €16.13. The BUY prediction by Morgan_Stanley for Acadia Pharmaceuticals performed very badly with a performance of -41.15%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -1.867% | -1.867% | 40.139% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $31.00.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.27
12.07.24
12.07.24
€25.68
12.07.25
12.07.25
9.19%
13.07.25
13.07.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.30
18.03.24
18.03.24
€27.59
18.03.25
18.03.25
-8.24%
19.03.25
19.03.25